HK Stock MarketDetailed Quotes
09939 KINTOR PHARMA-B
- 1.060
- -0.010-0.93%
Not Open Nov 25 16:08 CST
474.35MMarket Cap-470P/E (TTM)
1.070High1.040Low212.00KVolume1.070Open1.070Pre Close224.59KTurnover0.05%Turnover RatioLossP/E (Static)447.50MShares2.05052wk High1.11P/B474.35MFloat Cap0.79052wk Low--Dividend TTM447.50MShs Float89.000Historical High--Dividend LFY2.80%Amplitude0.790Historical Low1.059Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
KINTOR PHARMA-B Key Stats
EPS
According to the latest financial report of KINTOR PHARMA-B, the latest earnings per share (TTM) for the company is -0.19. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out KINTOR PHARMA-B's latest financial report to see how much their book value per share (BVPS) is currently at 0.96.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of KINTOR PHARMA-B shows that the company's current ratio is 1.56, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of KINTOR PHARMA-B, the quick ratio is 1.56, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of KINTOR PHARMA-B? The latest ROE figure is -16.76%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of KINTOR PHARMA-B, the total asset return on investment (ROA) is -8.85%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check KINTOR PHARMA-B's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of KINTOR PHARMA-B, the net profit margin is -2.46K%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data